February 2026
1. LI ZY, Li HL, Wang J, Shen QM, et al
   Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis.
   PLoS Med. 2026;23:e1004910.
   

   >> Share

   
   January 2026
2. YANG K, Lee J, Jang JW, Sung PS, et al
   Evaluating the clinical utility of large language models for hepatocellular carcinoma treatment recommendations: A nationwide retrospective registry study.
   PLoS Med. 2026;23:e1004855.
   

   >> Share

   
   October 2024
3. JEPSEN P, West J, Larsen AKK, Kann AE, et al
   Adverse health outcomes in offspring of parents with alcohol-related liver disease: Nationwide Danish cohort study.
   PLoS Med. 2024;21:e1004483.
   

   >> Share

   
   
4. LAI R, Barnett S, Zhang X, Kam LY, et al
   Incidence rates of hepatocellular carcinoma based on risk stratification in steatotic liver disease for precision medicine: A real-world longitudinal nationwide study.
   PLoS Med. 2024;21:e1004479.
   

   >> Share

   
   May 2024
5. WANG DS, Ren C, Li SS, Fong WP, et al
   Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
   PLoS Med. 2024;21:e1004389.
   

   >> Share

   
   January 2024
6. CHEN S, Ahlqvist VH, Sjoqvist H, Stephansson O, et al
   Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children.
   PLoS Med. 2024;21:e1004331.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share